Pharmaceutical Drugs Based On Cannabis

[EDDIEKIRK]

Pharmaceutical Drugs Based on Cannabis Pharmaceutical drugs have been developed which either contain or have similar chemicals as those found in the marijuana (cannabis) plant. Some researchers have used their understanding of how the brain processes cannabinoids to develop drugs which follow the same pathways but work differently than marijuana. Pharmaceutical drugs based on marijuana are divided into four categories and listed below with the names, trade names, manufacturers, approval status, suggested medical use and cannabis-related properties. All drugs referenced are in pill form unless otherwise noted.



Approved and launched in the UK on June 21, 2010, making it the first cannabis-based prescription medicine in the world. Licensed to Bayer in the UK and to Almirall in Europe. Approved to treat spasticity caused by multiple sclerosis in Spain (July 28, 2010), Canada (Aug. 31, 2010), Czech Republic (Apr. 15, 2011), Denmark (June 8, 2011), Germany (July 4, 2011), Sweden (Dec. 22, 2011), and Austria (Feb. 7, 2012).

In the US, Phase III clinical trials started in late 2006 for treatment of pain in cancer patients. On Apr. 20, 2011, a US patent was granted for Sativex in cancer pain.

GW Pharmaceuticals stated in a

July 28, 2010 press release (700 KB) that it expects Sativex to be approved in other European countries (including France and Italy) in 2011.

My link